Dr. William Kevin Kelly DO
Oncologist | Medical Oncology
925 Chestnut St Suite 320a Philadelphia PA, 19107Rating
4/5
About
Dr. William Kelly is an oncologist practicing in Philadelphia, PA. Dr. Kelly specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Kelly manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Philadelphia College of Osteopathic Medicine 1986
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Novel trial designs: which agents and how do we test them?
- Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration.
- The development of differentiation agents for the treatment of prostate cancer.
- Bisphosphonates for men with prostate cancer: sifting through the rubble.
- Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.
- Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
- Use of nomograms for predicting survival in patients with castrate prostate cancer.
- Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.
- Histone deacetylase inhibitors.
- Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma.
- Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.
- Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
- Second-line chemotherapy for prostate cancer: patient characteristics and survival.
- High-risk localized prostate cancer: a case for early chemotherapy.
- Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid.
Clinical Trials
Treatments
- Prostate Cancer
- Kidney Cancer
- Testicular Cancer
Dr. William Kevin Kelly DO's Practice location
Practice At 925 Chestnut St Suite 320a
925 Chestnut St Suite 320a -Philadelphia, PA 19107Get Direction
Dr. William Kevin Kelly DO's reviews
Write ReviewPatient Experience with Dr. Kelly
Recommended Articles
![]()
Three Women in One Family Battle Breast Cancer TogetherGenetics are a risk factor that no one can avoid when it comes to having a higher risk of disease. Genes passed down from parents inform the way that every cell grows and behaves.Breast cancer is one of the diseases that has a hereditary risk factor. It is estimated that between 5% and 10% of all...
![]()
What Are the Causes and Symptoms of Liver Cancer?Liver cancer, or hepatic cancer, is one of the most common forms of cancer. It is caused by abnormal growth and division of cells of the organ. This cancer may develop in the liver or spread from other organs of the body. Many of the liver cancers are spread from other parts of the body and are...
![]()
“Cancer Anger” - An ExplanationFollowing a cancer diagnosis, it is normal to be overwhelmed with a lot of different emotions. Some individuals may feel shocked and frightened, while others may feel sad, guilty, or upset. There is no right way to feel. ...
![]()
How Retaining One Normal BRCA Gene Influences Survival in Ovarian Cancer PatientsThe National Cancer Institute reports that around 250,000 people will be diagnosed with breast cancer this year, and about 22,000 with ovarian cancer. While the survival rate among patients with breast cancer is significantly higher compared to ovarian cancer – the NCI reports about 40,000 of the...
![]()
Why We Can’t Treat All Ovarian Cancer the Same WayOver the last three decades, ovarian cancer survival rates have seen very little improvement. The current five-year survival rate for ovarian cancer is 43%, a low percentage that is a result of the fact that this type of cancer is difficult to detect and often goes undiagnosed until it has reached...
![]()
This Unique Tattoo Helps Women Feel Complete After MastectomyEvery year, over 250,000 women receive news that they have been diagnosed with breast cancer. A large percentage of them end up undergoing mastectomies. During a mastectomy, the diseased breast tissue is removed, as well as the nipples and areolas. Women who choose to undergo breast reconstruction...
Nearby Providers
![]()
Dr. Vijay K. Gandhi M.D.333 COTTMAN AVE PHILADELPHIA PA 19111![]()
Dr. Jon Glass MD909 Walnut St Philadelphia PA 19107![]()
Dr. Crystal S. Denlinger M.D.333 COTTMAN AVE PHILADELPHIA PA 19111![]()
Eiko Klimant201 West Evergreen Avenue Philadelphia Pennsylvania 19118![]()
Dr. Shayma Master Kazmi MD1331 E Wyoming Ave Philadelphia PA 19124![]()
Dr. Andres Ferber M.D.900 Centennial Blvd Voorhees NJ 08043
Nearest Hospitals
THOMAS JEFFERSON UNIVERSITY HOSPITALl
111 SOUTH 11TH STREET PHILADELPHIA PA 19107PENNSYLVANIA HOSPITALl
800 SPRUCE STREET PHILADELPHIA PA 19107HAHNEMANN UNIVERSITY HOSPITALl
230 NORTH BROAD STREET PHILADELPHIA PA 19102